Crossmark

HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation

Crossref DOI link: https://doi.org/10.1186/1755-1536-7-10

Published Online: 2014-07-02

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nural-Guvener, Hikmet F

Zakharova, Luidmila

Nimlos, James

Popovic, Snjezana

Mastroeni, Diego

Gaballa, Mohamed A
More Information

Article History

Received: 22 January 2014

Accepted: 2 June 2014

First Online: 2 July 2014